メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

新興画像診断の世界市場の考察・機会分析・市場シェア・将来予測

Emerging Diagnostic Imaging Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 345633
出版日 ページ情報 英文 140 pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。
Back to Top
新興画像診断の世界市場の考察・機会分析・市場シェア・将来予測 Emerging Diagnostic Imaging Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日: 2016年02月29日 ページ情報: 英文 140 pages
概要

複合的診断が可能な設備に対する需要があるなか、ポータブル診断装置はポイントオブケアを支援しより多くの患者が利用できるという点で大きな進歩のひとつです。米国は世界最大の医療市場ですが、リソースとスキルが不足した業界において価値あるサービスと製品に対する需要が高まっています。

当レポートでは、新興の画像診断市場について調査し、市場の動向と2021年までの収益予測と成長率、業界分析、競合動向、地域別動向、および参入する主要企業のプロファイルをまとめています。

第1章 エグゼクティブサマリー

第2章 主な調査結果

第3章 セクタ―分析:医療機器市場

  • 画像診断システムへの方向性

第4章 法規制の影響

  • イントロダクション
    • 欧州
    • 米国
  • アジア太平洋地域

第5章 市場決定因子

  • 市場促進因子
    • 高齢化
    • 生活習慣病および慢性疾患の増加
    • その他
  • 機会

第6章 画像診断装置市場

  • MRIシステム
  • 超音波技術
  • インターベンショナルラジオロジー
  • 核医学

第7章 地域別分析

  • 北米
  • 欧州
  • アジア

第8章 企業プロファイル

  • LUMENIS LTD.
  • BIOLASE
  • PHOTOMEDEX
  • IRIDEX CORPORATION
  • SPECTRANETICS CORPORATION
  • GE HEALTHCARE
  • SIEMENS HEALTHCARE
  • PHILIPS HEALTHCARE
  • ABBOTT LABORATORIES
  • AGILENT TECHNOLOGIES
  • BIO RAD LABORATORIES
  • BRACCO IMAGING
  • CARDINAL HEALTH
  • COVIDIEN PLC

図表

目次
Product Code: HME-671114

The emerging diagnostic imaging market is segmented on the basis of applications such as advanced conventional technologies, remote diagnostics, point-of-care diagnostics, nuclear medicine, biomarkers, imaging agents and other emerging technologies. The report includes emerging technologies which are commercialized and which are going through final phases of approvals. Market covered in the emerging diagnostic imaging are North America, Latin America, Europe, Middle-East and Africa (MEA) and Asia-Pacific.

The diagnostic equipment of conventional technologies are over burdened with the hospitals and diagnostic centers having limited resources and budgets, especially in emerging markets like India and China. Hence there is requirement of machines that are capable of performing multiple diagnoses. Portable diagnostic machines are one of the major advancement which enables providing point-of-care assistance and reaching out to more number of patients.

United States being the largest healthcare market is number one in making changes so that healthcare can become more affordable to people. There is an increase in demand of services as well as products that are value based in the industry that lacks resources as well as skills. Opportunities are growing for the industry with the emergence of new markets. They are situated in the developing economies with ever changing needs.

This Occams Research Report covers

  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR upto 2022
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data
  • 6. Deep profiles top competitive companies

Table of Contents

Chap 1. Executive Summary

Chap 2. Key Findings

  • 2.1. Finding 1: What is the need of hour for med imaging cos? - Patient care/Innovations/Cost/Novel Business Model?
  • 2.2. Finding 2: How are regulations to affect the future market?
  • 2.3. Finding 3: Brown Water Strategy - Understanding Regional Markets

Chap 3. SECTOR ANALYSIS: Medical Devices Market

  • 3.1. Orientation to Diagnostic Imaging Systems

Chap 4. Regulatory Implications

  • 4.1. INTRODUCTION
    • 4.1.1. Europe
      • 4.1.1.1. ROHS II
    • 4.1.2. U.S.
      • 4.1.2.1. Class I devices
      • 4.1.2.2. Class II devices
      • 4.1.2.3. Class III devices
  • 4.2. China
    • 4.2.1. Japan
    • 4.2.2. India
    • 4.2.3. Indonesia
    • 4.2.4. Korea
    • 4.2.5. Malaysia
    • 4.2.6. The Philippines
    • 4.2.7. Singapore
    • 4.2.8. Taiwan
    • 4.2.9. Australia
    • 4.2.10. Hong Kong
    • 4.2.11. Vietnam

Chap 5. Market Determinants

  • 5.1. Market Drivers
    • 5.1.1. Aging population- A global issue to boost the need for diagnostics
    • 5.1.2. Increase in lifestyle and chronic diseases
    • 5.1.3. Other drivers include:
      • 5.1.3.1. Limitations and Restrictions
      • 5.1.3.2. Some other restrictive factors that are likely to impact the industry negatively are:
    • 5.1.4. Opportunities

Chap 6. Diagnostic Imaging Devices Market

  • 6.1. Magnetic Imaging Resonance (MRI) System
  • 6.2. Rest of World
    • 6.2.1. Market Dynamics
    • 6.2.2. Competitive Intelligence & Key Strategies
      • 6.2.2.1. GE Healthcare
      • 6.2.2.2. Toshiba
      • 6.2.2.3. Siemens
      • 6.2.2.4. Hitachi
      • 6.2.2.5. Philips
    • 6.2.3. Market Share of Key Companies, 2012
    • 6.2.4. Market Trends and Determinants
    • 6.2.5. Geographic Analysis
      • 6.2.5.1. Ultrasound Technologies Market
    • 6.2.6. Market Trends and Determinants
    • 6.2.7. Competitive Intelligence & Key Strategies
    • 6.2.8. Geographic Analysis
    • 6.2.9. Laser Imaging Market
    • 6.2.10. Market Determinants
    • 6.2.11. Competitive Intelligence and Key Strategies
    • 6.2.12. Company Market Share, 2012
    • 6.2.13. Geographic Analysis
      • 6.2.13.1. Interventional Radiology Market
    • 6.2.14. Market Trends and Determinants
    • 6.2.15. Competitive intelligence and Key strategies
    • 6.2.16. Geographic Analysis
      • 6.2.16.1. X-ray
    • 6.2.17. Market determinants
    • 6.2.18. Competitive Intelligence & key Strategies
    • 6.2.19. Market share of key players, 2012
    • 6.2.20. Geographic Analysis
      • 6.2.20.1. Nuclear Medicine
    • 6.2.21. Market determinants
    • 6.2.22. Competitive Intelligence & Key Strategies
    • 6.2.23. Market share of key players, 2012
    • 6.2.24. Geographic Analysis

Chap 7. Geography Analysis

  • 7.1. North America
    • 7.1.1. U.S.
    • 7.1.2. Canada
      • 7.1.2.1. Europe
    • 7.1.3. Enabling people to live healthy and productive lives
    • 7.1.4. Increasing the productivity and efficiency of healthcare systems
    • 7.1.5. Contributing to economic growth
      • 7.1.5.1. Benefits of the EU regulatory system in access to novel technologies
  • 7.2. Asia
    • 7.2.1. Population Size
    • 7.2.2. Economics
    • 7.2.3. Aging Populations
      • 7.2.3.1. Asia's Growing Market for Cardiovascular Devices
    • 7.2.4. RAPIDLY GROWING DEMAND
    • 7.2.5. Each country in Asia has different medical device regulations and classifications, usually based on the level of risk to the patient.
      • 7.2.5.1. Outsourcing Medical Devices to Asia: Trends and Tips
    • 7.2.6. Conclusion
    • 7.2.7. Increased Medical Device Regulations for Asia's New Tigers
    • 7.2.8. China
      • 7.2.8.1. Understanding the China Medical Device Market
      • 7.2.8.2. China Regulatory Agency for Medical Devices
      • 7.2.8.3. Major healthcare issues for China to tackle include
      • 7.2.8.4. Healthcare Development in Rural and Urban Areas
      • 7.2.8.5. Greater Private-Sector Opportunities
      • 7.2.8.6. More Affordable Healthcare
      • 7.2.8.7. Tighter Medical Device Regulations
      • 7.2.8.8. The Battle Over China's Medical Device Market 2013
    • 7.2.9. India
    • 7.2.10. Japan
    • 7.2.11. Korea
    • 7.2.12. MALAYSIA
      • 7.2.12.1. The Medical Device Act
      • 7.2.12.2. The Medical Device Authority Act
    • 7.2.13. INDONESIA
      • 7.2.13.1. Infrastructure growth4
      • 7.2.13.2. Online registration system
    • 7.2.14. THAILAND
    • 7.2.15. VIETNAM
    • 7.2.16. SINGAPORE
    • 7.2.17. South Korea
      • 7.2.17.1. Rest of The World
    • 7.2.18. Turkey
    • 7.2.19. Iran
    • 7.2.20. Brazil

Chap 8. Company profiles

  • 8.1. LUMENIS LTD.
  • 8.2. BIOLASE
  • 8.3. PHOTOMEDEX
  • 8.4. IRIDEX CORPORATION
  • 8.5. SPECTRANETICS CORPORATION
  • 8.6. GE HEALTHCARE
  • 8.7. SIEMENS HEALTHCARE
  • 8.8. PHILIPS HEALTHCARE
  • 8.9. ABBOTT LABORATORIES
  • 8.10. AGILENT TECHNOLOGIES
  • 8.11. BIO RAD LABORATORIES
  • 8.12. BRACCO IMAGING
  • 8.13. CARDINAL HEALTH
  • 8.14. COVIDIEN PLC
Back to Top